(Q34502702)
Statements
1 reference
Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States (English)
1 reference
Mitsuo Saito
1 reference
Mutsuko Hirata-Koizumi
1 reference
Shinji Miyake
1 reference
Ryuichi Hasegawa
1 reference
1 January 2005
1 reference